Four young physician-researchers at P&S have received research funding from the Louis V. Gerstner Jr. Scholar Program.
Study finds tiny, targeted drug particles may be effective in treating chronic diseases
Scientists discovered how common genetic mutations in Parkinson’s disease damage brain cells
CUMC neuroscientist Asa Abeliovich and his team have identified a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson’s disease.
Researchers identify mechanism for non-familial form of Parkinson’s disease. May lead to therapeutic targets & blood test for PD.
New research by Andreas H. Kottmann, PhD, on signaling protein “sonic hedgehog” adds to understanding of Parkinson’s disease.